Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000409440 | SCV000486227 | likely pathogenic | Achromatopsia 3 | 2016-04-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001861379 | SCV002231796 | pathogenic | not provided | 2024-03-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg138Glufs*14) in the CNGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNGB3 are known to be pathogenic (PMID: 28795510). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with CNGB3-related conditions. ClinVar contains an entry for this variant (Variation ID: 370817). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000409440 | SCV005679227 | likely pathogenic | Achromatopsia 3 | 2024-02-14 | criteria provided, single submitter | clinical testing |